01826oam 2200421I 450 991070617310332120170913092611.0(CKB)5470000002454694(OCoLC)1001810997(OCoLC)995470000002454694(EXLCZ)99547000000245469420170824d2017 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierDrug control policy, information on status of federal efforts and key issues for preventing illicit drug use: testimony before the Committee on Oversight and Government Reform, House of Representatives /statement of Diana Maurer[Washington, D.C.] :United States Government Accountability Office,2017.1 online resource (15 pages) color illustrationsTestimony ;GAO-17-766T"For release ... July 26, 2017."Includes bibliographical references.Drug control policy, information on status of federal efforts and key issues for preventing illicit drug useDrug controlUnited StatesEvaluationDrug abuseGovernment policyUnited StatesDrug controlEvaluation.Drug abuseGovernment policyMaurer DianaUnited States.Congress.House.Committee on Oversight and Government Reform,GPOGPOMERUCGPOBOOK9910706173103321Drug control policy, information on status of federal efforts and key issues for preventing illicit drug use: testimony before the Committee on Oversight and Government Reform, House of Representatives3281897UNINA